These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38985856)

  • 1. Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation.
    Zhu W; Du W; Rameshbabu AP; Armstrong AM; Silver S; Kim Y; Wei W; Shu Y; Liu X; Lewis MA; Steel KP; Chen ZY
    Sci Transl Med; 2024 Jul; 16(755):eadn0689. PubMed ID: 38985856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation.
    Zhu W; Du W; Rameshbabu AP; Armstrong AM; Silver S; Kim Y; Wei W; Shu Y; Liu X; Lewis MA; Steel KP; Chen ZY
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing in a Myo6 semi-dominant mouse model rescues auditory function.
    Xue Y; Hu X; Wang D; Li D; Li Y; Wang F; Huang M; Gu X; Xu Z; Zhou J; Wang J; Chai R; Shen J; Chen ZY; Li GL; Yang H; Li H; Zuo E; Shu Y
    Mol Ther; 2022 Jan; 30(1):105-118. PubMed ID: 34174443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing.
    Gu X; Wang D; Xu Z; Wang J; Guo L; Chai R; Li G; Shu Y; Li H
    Genome Biol; 2021 Mar; 22(1):86. PubMed ID: 33752742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia.
    Pan X; Philippen L; Lahiri SK; Lee C; Park SH; Word TA; Li N; Jarrett KE; Gupta R; Reynolds JO; Lin J; Bao G; Lagor WR; Wehrens XHT
    Circ Res; 2018 Sep; 123(8):953-963. PubMed ID: 30355031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents.
    Gao X; Tao Y; Lamas V; Huang M; Yeh WH; Pan B; Hu YJ; Hu JH; Thompson DB; Shu Y; Li Y; Wang H; Yang S; Xu Q; Polley DB; Liberman MC; Kong WJ; Holt JR; Chen ZY; Liu DR
    Nature; 2018 Jan; 553(7687):217-221. PubMed ID: 29258297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo.
    Tao Y; Lamas V; Du W; Zhu W; Li Y; Whittaker MN; Zuris JA; Thompson DB; Rameshbabu AP; Shu Y; Gao X; Hu JH; Pei C; Kong WJ; Liu X; Wu H; Kleinstiver BP; Liu DR; Chen ZY
    Nat Commun; 2023 Aug; 14(1):4928. PubMed ID: 37582836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
    Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
    Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.
    Farooq R; Hussain K; Tariq M; Farooq A; Mustafa M
    J Appl Genet; 2020 Feb; 61(1):51-65. PubMed ID: 31912450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae.
    Zhao X; Jin C; Dong T; Sun Z; Zheng X; Feng B; Cheng Z; Li X; Tao Y; Wu H
    Hear Res; 2020 Sep; 394():107999. PubMed ID: 32611519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene editing based hearing impairment research and therapeutics.
    Kang W; Sun Z; Zhao X; Wang X; Tao Y; Wu H
    Neurosci Lett; 2019 Sep; 709():134326. PubMed ID: 31195050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single and Dual Vector Gene Therapy with AAV9-PHP.B Rescues Hearing in Tmc1 Mutant Mice.
    Wu J; Solanes P; Nist-Lund C; Spataro S; Shubina-Oleinik O; Marcovich I; Goldberg H; Schneider BL; Holt JR
    Mol Ther; 2021 Mar; 29(3):973-988. PubMed ID: 33212302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss.
    György B; Nist-Lund C; Pan B; Asai Y; Karavitaki KD; Kleinstiver BP; Garcia SP; Zaborowski MP; Solanes P; Spataro S; Schneider BL; Joung JK; Géléoc GSG; Holt JR; Corey DP
    Nat Med; 2019 Jul; 25(7):1123-1130. PubMed ID: 31270503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
    Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
    BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins.
    Lee J; Mou H; Ibraheim R; Liang SQ; Liu P; Xue W; Sontheimer EJ
    RNA; 2019 Nov; 25(11):1421-1431. PubMed ID: 31439808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Duan W; Guo M; Yi L; Liu Y; Li Z; Ma Y; Zhang G; Liu Y; Bu H; Song X; Li C
    Gene Ther; 2020 Apr; 27(3-4):157-169. PubMed ID: 31819203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Adeno-Associated Viral Vectors That Target Neonatal and Adult Mammalian Inner Ear Cell Subtypes.
    Shu Y; Tao Y; Wang Z; Tang Y; Li H; Dai P; Gao G; Chen ZY
    Hum Gene Ther; 2016 Sep; 27(9):687-99. PubMed ID: 27342665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.
    Zhang Y; Li H; Min YL; Sanchez-Ortiz E; Huang J; Mireault AA; Shelton JM; Kim J; Mammen PPA; Bassel-Duby R; Olson EN
    Sci Adv; 2020 Feb; 6(8):eaay6812. PubMed ID: 32128412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.